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SCIENTIFIC ARTICLE 
Predicting Red Blood Cell Transfusions in Very Low Birth 
Weight Infants Based on Clinical Risk Factors 
David A. Paul, M.D. — Stephen A. Pearlman, M.D. — Kathleen H. Leef, R.N. 
John L. Stefano, M.D. 
ABSTRACT 
Objective: to describe the clinical factors most predictive of red blood cell transfusion in very low birth weight 
(VLBW) infants. 
Study design: retrospective review of VLBW infants cared for at a single level III N ICU during a two year 
period, n=199. 
Results: overall transfusion requirement was 4.6 ± 6.2 transfusions/infant/hospital course. Length of hospital 
stay, days of mechanical ventilation, requirement for dopamine support, birth weight, initial hematocrit, 
periventricular leukomalacia and necrotizing enterocolitis all independently correlated with number of 
transfusions and donors. Bronchopulmonary dysplasia and patent ductus arteriosus were associated with 
donor but not transfusion number. 
Conclusions: our data characterize the population of VLBW infants with the greatest blood transfusion and 
donor requirement. Further investigation is needed to target this population for interventions to reduce blood 
exposure. 
Anemia of prematurity with the subsequent need 
to transfuse red blood cells (RBC) is a common 
problem in preterm infants. The most promising 
intervention to reduce the number of RBC trans-
fusions in preterm infants has been the use of 
recombinant human erythropoietin which has 
been shown to safely stimulate erythropoiesis 
and decrease the requireent for transfusions in 
selected preterm infants. 	 Other interventions 
such as transfusion of placental blood, 4 and 
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changing the preservative of red blood cells to 
allow transfusion of older blood 5 have also 
been suggested in order to decrease postnatal 
donor exposure but have not been extensively 
investigated in studies involving large numbers 
of infants. 	 To date, the sub-population of 
preterm infants who would most likely benefit 
from these new therapies has been poorly de-
fined. The purpose of this study was to: 1) 
determine which preterm infants require the most 
transfusions of RBC and have the greatest donor 
exposure and 2) establish the population of 
infants that would potentially derive the greatest 
benefit from interventions to limit exposure to 
blood products. In order to meet these goals we 
retrospectively created multivariate linear re-
gression models to determine the clinical vari-
ables determining both RBC transfusion and 
donor number. 
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METHODS 
The study consisted of a retrospective review of 
infants admitted to the intensive care nursery at 
the Medical Center of Delaware from July 1, 
1993 to July 1, 1995. The Medical Center of 
Delaware is a level III neonatal intensive care 
unit caring for both inborn and outborn infants. 
All data were obtained from a review of a 
computerized database and confirmed by chart 
review. Infants were included in the analysis if 
they had a birth weight less than 1500 grams and 
were offered intensive care. In order to establish 
the relationship of blood transfusion with intra-
ventricular hemorrhage and bronchopulmonary 
dysplasia, infants were only included if they met 
the above criteria, had a minimum of one cranial 
sonogram, and survived to 28 days of life, 
n=199. Infants not analyzed included: 22 in-
fants who were admitted and transfused but died 
prior to 28 days of life, and two infants (1380 
grams and 1490 grams) not transfused who did 
not receive a cranial sonogram at the discretion 
of the attending neonatologist. 
For the purpose of this study, a blood transfusion 
was considered the administration of packed red 
blood cells as ordered by the attending neona-
tologist. All transfused blood is negative for 
cytomegalovirus, irradiated, less than seven days 
old and stored in citrate-phosphate-dextrose-
adenine preservative. Blood from a single do-
nor, which was ordered to be split into multiple 
smaller aliquots, and transfused within 24 hours, 
was considered a single transfusion. If an infant 
received a second transfusion > 24 hours fol-
lowing an original transfusion, but before the 
seven day expiration period of the blood, the 
transfusion was considered a second transfusion 
but a single donor exposure. Therefore infants 
often receive multiple transfusions from a single 
donor. All transfusions ordered after the seven 
day expiration period of the original unit were 
from a different donor. 
The following general criteria are adhered to in 
our nursery: most transfusions ranged from ten 
to 15 cc/kg per transfusion. During the acute 
phase of respiratory distress syndrome, infants 
are transfused to keep the hematocrit greater 
than 35-40 percent. Anemic preterm infants 
who are more stable and receiving enteral feeds 
and no supplemental oxygen were transfused 
only if they are felt to be symptomatic. These 
symptoms included: tachycardia, tachypnea, poor 
weight gain while receiving adequate calories, 
and frequent apnea unresponsive to other thera-
pies. 
The independent variables studied are listed 
(Table 1). For the purpose of this study gesta-
tional age was defined by the best obstetrical 
estimate or if not available by Ballard exam. 6 
Patients were given the diagnosis of bacterial 
sepsis if they had a positive blood culture and.the 
diagnosis of patent ductus arteriosus if con-
firmed by echocardiography. Bronchopulmo-
nary dysplasia was defined as a requirement for 
supplemental oxygen at 28 days of life. 7 Pro-
longed rupture of membranes was defined as 
being greater than 24 hours in duration. Prema-
ture rupture of membranes was defined as rup-
ture before 37 weeks of gestation. 
Multivariate linear regression models were cre-
ated in order to determine which clinical factors 
were most predictive of the number of transfu-
sions and the number of donors. Number of red 
blood cell transfusions and number of donors 
served as the dependent variables. Independent 
variables entered in the models were determined 
by performing a preliminary univariate analysis 
as well as multiple linear regressions. Forward 
stepwise analysis was performed in order to 
determine variables independently associated 
with transfusion and donor number. Validity of 
the models was confirmed by plotting residuals 
versus expected normal values and residuals 
versus predicted values. All data are expressed 
as mean ± standard deviation, unless otherwise 
noted. All statistical calculations were performed 
on commercially available software (Statistica, 
Tulsa, OK). 
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Table 1. Independent variables studied in multivariate 
models. Dependent variables, transfusion number and 
donor number. 
INDEPENDENT VARIABLES STUDIED 
Gestational Age 
Birth Weight 
Intrauterine Growth Restriction 
Length of Hospital Stay 
Gender 
Mechanical Ventilation 
High Frequency Ventilation 
Days of Mechanical Ventilation 
Continuous Positive Airway Pressure 
Days of Continuous Positive Airway Pressure 
Days of Supplemental Oxygen 
Prenatal Steroids 
Exogenous Surfactant 
Apnea of Prematurity 
Caffeine 
Dopamine 
Dobutamine 
Initial Hematocrit 
Patent Ductus Arteriosus 
Bacterial Sepsis 
Intraventricular Hemorrhage 
Severe Intraventricular Hemorrhage, grade III-IV 
Periventricular Leukomalacia 
Necrotizing Enterocolitis 
Bronchopulmonary Dysplasia 
Seizures 
Pneumothorax 
Mortality 
Preeclampsia 
Premature Labor 
Maternal Substance Abuse 
Multiple Gestation 
Prolonged Rupture of Membranes 
Premature Rupture of Membranes 
Maternal Urinary Tract Infection 
Chorioamnionitis 
Oligohydramnios 
Maternal Age 
Number of Platelet Transfusions 
Prenatal magnesium sulfate  
RESULTS 
The overall requirement for transfusions of RBC 
was 4.6 ± 6.2 per infant/hospital course (range 
0-40). Thirty-five percent of the study population 
did not require any RBC transfusions throughout 
their hospital course, while five percent required 
only a single transfusion, 13 percent required 
two to three RBC transfusions, 12 percent re-
quired four to five RBC transfusions and the 
remaining 35 percent required six or more trans-
fusions. The mean number of donors was 2.6 ± 
3.1 per infant / hospital course (range 0 -17). 
Thirty-five percent had no donor exposures, while 
ten percent had a single exposure, 20 percent 
had two to three exposures, 18 percent had four 
to five exposures, and the remaining 17 percent 
had six or more RBC donors. None of the infants 
in the study received recombinant erythropoi-
etin. The demographic makeup of the study 
population is listed in Table 2. 
Variables independently correlating with number 
of RBC transfusions included: length of hospital 
stay (p<.00001), number of days of mechanical 
ventilation (p < .0001), requirement for dopam-
ine support (p< .00001), diagnoses of 
periventricular leukomalacia (p=.00004) and 
necrotizing enterocolitis (p= .002), birth weight 
(p=.002), and initial hematocrit (p=.04). The 
overall model had an r=0.9 (p<.001). None of 
the other variables studied (Table 1) correlated 
with number of transfusions. 
Variables associated with number of donors 
included: length of hospital stay (p<.00001), 
number of days of mechanical ventilation (p < 
.00001), requirement for dopamine support (p< 
.00001), diagnoses of bronchopulmonary dys-
plasia (p=.0004) and periventricular 
leukomalacia (p=.01), birth weight (p=.03), 
initial hematocrit (p=.03) and diagnoses of ne-
crotizing enterocolitis (p= .03) and patent duc-
tus arteriosus (p=.04). The overall model had 
an r=0.91 (p<.00001). None of the other vari-
ables studied (Table 1) were associated with 
number of donors. 
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DEMOGRAPHIC DATA (n=199) 
Birth Weight (grams) 1089 ± 279* 
Gestational Age (weeks) 28.5 ± 2.9* 
Apgar Score -1 minute 5.0** 
Apgar Score-5 minutes 8.0** 
Male Gender 107 (54%) 
C-section 107 (54%) 
CPAP 151 (76%) 
Mechanical Ventilation 148 (74%) 
Patent Ductus Arteriosus 36 (18%) 
Intraventricular Hemorrhage (grade I-IV) 27 (14%) 
Bronchopulmonary Dysplasia 92 (46%) 
Sepsis 34 (17%) 
Necrotizing Enterocolitis 13 (7%) 
Dopamine 41 (21%) 
Exogenous Surfactant 141 (71%) 
Initial Hematocrit (%) 45.1 ±7.5* 
Length of Stay (days) 63.8 ± 27.6* 
* Mean ± sd 
** Median 
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Because most of the variables correlating with 
number of transfusions and number of donors in 
the above models are not known until later in an 
infant's hospital course, an attempt was made to 
create a model using variables available at the 
time of birth. Using only birth weight and initial 
hematocrit as the independent variables and 
transfusion number as the dependent variable 
had an r =.71 (p<.001). Using donor number 
as the dependent variable with the same inde-
pendent variables had an r=.69 (p<.001). 
DISCUSSION 
The etiology of the anemia of prematurity is 
multifactorial. The pathophysiology results from 
an attenuated erythropoietin response to tissue 
hypoxia, 8 iatrogenic blood loss, 9,10 and short-
ened life span of RBC containing fetal hemoglo-
bin. 9 Although the risk of HIV infection from 
random donor blood is one in 450,000 to one in 
600,000 in the United States, 11 transfusion of 
blood products is associated with significant 
parental anxiety. Other risks from exposure to 
blood products include: hepatitis B and C, as 
well as volume overload, electrolyte disturbances, 
iron overload and graft versus host disease.12 
These risks highlight the importance of develop-
ing methods to decrease transfusion and donor 
number in this population. Our data demon-
strate that length of hospital stay, days of me-
chanical ventilation and need for dopamine 
support are the variables most predictive of 
number of transfusions and donors. Birth weight, 
initial hematocrit, periventricular leukomalacia 
and necrotizing enterocolitis are also indepen-
dent predictors of transfusion and donor num-
ber. Diagnosis of patent ductus arteriosus and 
bronchopulmonary dysplasia are related to do-
nor number but not transfusion number. 
To our knowledge this report is the first to 
correlate length of hospital stay with transfusion 
and donor number. We speculate that infants 
with prolonged length of stay had increased 
phlebotomy losses. Obladen et al have previ- 
Table 2. Demographic make-up of the study population. 
ously demonstrated that infants of lower birth 
weight and infants who require respiratory sup-
port have increased blood sampling. 10 
 Phle-
botomy data was not included in this investiga-
tion because it was not uniformly available in our 
population. Number of transfusions and donors 
may also be related to length of stay because of 
a prolonged opportunity to transfuse infants, as 
the hematocrit of infants discharged to home is 
generally unknown to the attending physician. 
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Further investigation is needed to study the strong 
association of length of stay with transfusion and 
donor number. 
In addition to length of stay, prolonged me-
chanical ventilation was associated with transfu-
sion and donor number in our population. Again, 
this finding may be secondary to higher phle-
botomy requirements in preterm infants with a 
need for supplemental oxygen. 10 However, the 
exact hemoglobin and level of respiratory sup-
port at which oxygen delivery becomes compro-
mised is unknown and can only be estimated 
based on unreliable clinical parameters. Our 
finding that periventricular leukomalacia, necro-
tizing enterocolitis, and use of dopamine are 
associated with transfusion and donor number 
reflect the requirement for transfusion in condi-
tions with impaired tissue oxygenation. Our data 
emphasize the need to target infants with these 
conditions for reducing donor exposure. Inves-
tigation of the relationship between oxygen sup-
ply and demand in infants with hypotension, 
respiratory compromise, intestinal and cerebral 
ischemia would aid in establishing strict guide-
lines for transfusing infants with these conditions. 
An important part of the pathophysiology of the 
anemia of prematurity involves diminished re-
sponse of premature infants in producing eryth-
ropoietin to a hypoxic stimulus. 8 Because of this 
attenuated ability to produce endogenous eryth-
ropoietin, treatment with recombinant human 
erythropoietin has been employed as a therapy 
for anemia of prematurity. " However, the 
population of preterm infants who would derive 
the greatest benefit from this therapy has yet to 
be elucidated. In our population of VLBW in-
fants, birth weight and initial hematocrit were 
predictive of transfusion and donor number. 
Gestational age was not predictive after multi-
variate analysis. This relationship is due to close 
correlation of the two variables, with birth weight 
superseding gestational age in the multivariate 
models. Brown et al have previously demon-
strated gestational age less than 30 weeks to be 
most predictive of the need for greater than two 
transfusions. 14 
 In contrast to this data which 
indicate that infants of the youngest gestational 
age receive the highest number of transfusions, 
previous studies have shown that recombinant 
human erythropoietin is most effective when 
administered to larger infants. 2,3 Only one 
double blind placebo controlled study of recom-
binant erythropoietin has include infants less 
than 750 grams. 1 
 Furthermore, Maier et al 
demonstrated that low birth weight and gesta-
tional age were most predictive of transfusion in 
a population of infants receiving erythropoi-
etin: Although our data indicate that recombi-
nant human erythropoietin would have the great-
est impact if offered to the smallest infants, 
administration of erythropoietin to extremely low 
birth weight infants (<1000g) may be limited by 
the need to supplement enteral iron and the 
need for frequent intramuscular injections. 16 
Additional study is needed to determine how to 
safely and effectively administer this drug to 
infants of the lowest birth weight. 
Anemia of prematurity has been .Dreviously clas-
sified into early and late anemia. Early anemia 
of prematurity is associated with high phlebotomy 
losses. This association was emphasized in the 
erythropoietin trial of Shannon et al, in which 
infants received a mean of 3.5 transfusions prior 
to enrollment. 1 In our population, bronchopul-
monary dysplasia and patent ductus arteriosus 
were predictive of donor number but not transfu-
sion number. The need for surgical ligation of a 
patent ductus has previously been shown to be 
associated with increased blood transfusion. 14 
We speculate that these factors were associated 
with donor number and not transfusion number 
in our population, because infants with these 
conditions continued to receive transfusions later 
in their hospital course at which time they are 
likely to be exposed to a new donor with each 
transfusion. 
Many of the variables associated with donor and 
transfusion number in our investigation are not 
known to the clinician at the time of birth; for 
example, the diagnosis of bronchopulmonary 
dysplasia or the length of hospital stay. Although 
our data indicate that these factors are important 
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in contributing to the need for transfusion, it may 
be difficult to develop a treatment strategy using 
these variables. A more useful model may be 
one using variables known at birth, allowing 
early intervention, since the majority of transfu-
sions occur during the early part of an infant's 
hospital stay. 17 The models created using only 
birth weight and initial hematocrit correlated 
well with transfusion and donor number. There-
fore, these clinical variables, while not account-
ing for all the clinical conditions and variability 
associated with RBC transfusion, may be used 
early in an infant's hospital course to predict 
transfusion number, initiate interventional strat-
egies, and counsel parents. 
In conclusion, our data are the first to demon-
strate an association between length of hospital 
stay, transfusion and donor number in a popula-
tion of VLBW infants. Defining the population of 
infants at greatest risk provides a target for 
intervention. Along with erythropoietin, strict 
transfusion criteria, strategies to decrease phle-
botomy losses, and autologous transfusion have 
all been proposed to decrease donor exposure 
in infants. Our data help to provide the ground 
work to identify a population of infants who 
would derive the greatest benefit from such 
interventions. Further investigation is needed in 
order to effectively apply these interventions to a 
target population. 
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